home / stock / xent / xent quote
Last: | $28.24 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $28.24 |
High: | $0 |
Low: | $0 |
Volume: | 14,512 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$28.24 | $0 | $28.24 | $0 | $0 | 14,512 | 09-16-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 3,200 | 09-15-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 2,786 | 09-13-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 1,312 | 09-12-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 964 | 09-09-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 16,200 | 09-08-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 9,252 | 09-07-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 4,410 | 08-26-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 442 | 08-25-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 2,858 | 08-09-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 2,602 | 08-05-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 6,192 | 08-04-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 298 | 08-03-2022 |
$28.24 | $0 | $28.24 | $0 | $0 | 2,058 | 07-29-2022 |
$28.24 | $28.25 | $28.24 | $28.25 | $28.23 | 838,270 | 05-12-2022 |
$28.24 | $28.24 | $28.24 | $28.25 | $28.22 | 917,007 | 05-11-2022 |
$28.24 | $28.2 | $28.24 | $28.25 | $28.2 | 2,583,672 | 05-10-2022 |
$27.82 | $27.65 | $27.82 | $27.89 | $27.65 | 358,200 | 05-09-2022 |
$27.81 | $27.8 | $27.81 | $27.95 | $27.8 | 531,888 | 05-06-2022 |
$27.82 | $27.88 | $27.82 | $28 | $27.35 | 622,211 | 05-05-2022 |
News, Short Squeeze, Breakout and More Instantly...
Data from first-of-its-kind study published in Current Medical Research and Opinion Patients receiving PROPEL ® following endoscopic sinus surgery had statistically significant lower healthcare resource utilization over a postoperative period of 18 months, including a...
Intersect ENT, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today reported financial results for the third quarter ended September 30, 2021. Total revenue was $24.4 million for the third qu...
Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that Helios Dr. Horst Schmidt Kliniken Wiesbaden in Germany was the first hospital outside the United States to...